Not all people with CLL demand therapy. Regardless of all new developments, the iwCLL however suggests watchful observation for sufferers with asymptomatic illness.86 This recommendation relies on no less than two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). 学習資料をアップロードして、すべてのドキュメ... https://popet752ltb8.wiki-cms.com/user